Nautilus Biotechnolgy financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

노틸러스 바이오테크놀로지NASDAQ:NAUT · Nasdaq · Healthcare

$1.96+24.84%

2026-10-02 close

Nautilus Biotechnolgy's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$81M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy